medigraphic.com
Instituto Nacional de Salud Pública

2021, Número 6

<< Anterior Siguiente >>

salud publica mex 2021; 63 (6)


Epidemiología de la hipertensión arterial en adultos mexicanos: diagnóstico, control y tendencias. Ensanut 2020

Campos-Nonato I, Hernández-Barrera L, Oviedo-Solís C, Ramírez-Villalobos D, Hernández B, Barquera S

Idioma: Español
Referencias bibliográficas: 31
Paginas: 692-704
Archivo PDF: 355.77 Kb.


RESUMEN

Objetivo. Describir la prevalencia de hipertensión arterial (HTA) en adultos mexicanos, la proporción que tiene tensión arterial (TA) controlada y la tendencia en el periodo 2018- 2020. Material y métodos. Se midió la TA a 9 844 adultos en la Encuesta Nacional de Salud y Nutrición (Ensanut) 2020. Se consideró que tenían HTA o TA controlada cuando cumplían los criterios del Eighth Joint National Committee (JNC-8) o American Heart Association (AHA). Resultados. La prevalencia de HTA fue 49.4% (según JNC-8), de los cuales 70% desconocía su diagnóstico. Según la clasificación AHA, 30.2% de los adultos tenía HTA y 51.0% ignoraba su diagnóstico. Entre adultos con diagnóstico previo de HTA, 54.9% tuvo TA controlada. Entre el periodo 2018-2020 no se observaron cambios en las prevalencias. Conclusiones. Al menos un tercio de los adultos mexicanos tiene HTA y de ellos al menos la mitad no habían sido diagnosticados. Debe evaluarse la pertinencia de los actuales programas de diagnóstico de HTA porque el subdiagnóstico y mal control pueden ocasionar complicaciones y la muerte.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. World Health Organization. A global brief on Hypertension. Silent killer, global public health crisis. Geneva: WHO, 2013. Disponible en: https://apps. who.int/iris/bitstream/handle/10665/79059/WHO_DCO_WHD_2013.2_ eng.pdf?sequence=1

  2. Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cifkova R, Dominiczak AF, et al. Hypertension. Nat Rev Dis Primers. 2018;4:18014. https://doi. org/10.1038/nrdp.2018.14

  3. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: Update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982-3021. https://doi.org/10.1016/j.jacc.2020.11.010

  4. World Health Organization. Global status report on noncommunicable diseases 2010. Chapter 4. Burden: mortality, morbidity and risk factors. Geneva: WHO; 2011. Disponible en: https://apps.who.int/iris/bitstream/ handle/10665/44579/9789240686458_eng.pdf;jsessionid=73C0B8958E48E B28C1D77FB17DB4E5CE?sequence=1

  5. Campos-Nonato I, Hernandez-Barrera L, Flores-Coria A, Gomez- Alvarez E, Barquera S. Prevalence, diagnosis and control of hypertension in Mexican adults with vulnerable condition. Results of the Ensanut 100k. Salud Publica Mex. 2019;61(6):888-97. https://doi.org/10.21149/10574

  6. Whelton PK, Carey RM, Aronow WS, Casey DE, Jr., Collins KJ, Dennison- Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluaisquemia tion, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127-e248. https://doi.org/10.1016/j.jacc.2017.11.006

  7. Campos-Nonato I, Hernandez-Barrera L, Pedroza-Tobias A, Medina C, Barquera S. Hypertension in Mexican adults: prevalence, diagnosis and type of treatment. Ensanut MC 2016. Salud Publica Mex. 2018;60(3):233- 43. https://doi.org/10.21149/8813

  8. Romero-Martínez M, Barrientos T, Cuevas-Nasu L, Shamah-Levy T, Bautista- Arredondo S, Colchero A, et al. Metodología Encuesta Nacional de Salud y Nutrición 2020 sobre Covid-19. Salud Publica Mex. 2021;63:444- 51. https://doi.org/10.21149/12580

  9. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45(1):142-61. https://doi. org/10.1161/01.HYP.0000150859.47929.8e

  10. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20. https://doi.org/10.1001/jama.2013.284427

  11. Lohman T, Roche M. Anthropometric standarization reference manual. Champlaign, IL: Human Kinetics, 1988.

  12. World Health Organization.. Physycal statuts: the use and interpretation of anthropometry. Geneva: WHO, 1995.

  13. Gotto AM, Ncep ATPIII. NCEP ATP III guidelines incorporate global risk assessment. Am J Manag Care. 2003;9(1):3-4.

  14. Konta T, Ichikawa K, Kawasaki R, Fujimoto S, Iseki K, Moriyama T, et al. Association between serum uric acid levels and mortality: a nationwide community-based cohort study. Sci Rep. 2020;10(1):6066. https://doi. org/10.1038/s41598-020-63134-0

  15. Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med. 2001;161(9):1207-16. https://doi.org/10.1001/archinte.161.9.1207

  16. American Diabetes A. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(supl 1):S15-S33. https://doi.org/10.2337/dc21-S002

  17. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223-37. https://doi.org/10.1038/s41581-019- 0244-2

  18. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441-50. https://doi.org/10.1161/CIRCULATIONAHA. 115.018912

  19. Sarki AM, Nduka CU, Stranges S, Kandala NB, Uthman OA. Prevalence of hypertension in low- and middle-income countries: a systematic review and meta-analysis. Medicine (Baltimore). 2015;94(50):e1959. https://doi. org/10.1097/MD.0000000000001959

  20. Sandberg K, Ji H. Sex differences in primary hypertension. Biol Sex Differ. 2012;3(1):7. https://doi.org/10.1186/2042-6410-3-7

  21. Cornoni-Huntley J, LaCroix AZ, Havlik RJ. Race and sex differentials in the impact of hypertension in the United States. The National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med. 1989;149(4):780-8.

  22. Reckelhoff JF. Gender differences in hypertension. Curr Opin Nephrol Hypertens. 2018;27(3):176-81. https://doi.org/10.1097/ MNH.0000000000000404

  23. Hall JE. The kidney, hypertension, and obesity. Hypertension. 2003;41(3):625-33. https://doi.org/10.1161/01.HYP.0000052314.95497.78

  24. Diaz ME. Hypertension and obesity. J Hum Hypertens. 2002;16 Suppl 1:S18-22. https://doi.org/10.1038/sj.jhh.1001335

  25. Viazzi F, Bonino B, Ratto E, Desideri G, Pontremoli R. Hyperuricemia, diabetes and hypertension. G Ital Nefrol. 2015;32(supl 62).

  26. Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet. 2012;380(9841):601-10. https://doi.org/10.1016/ S0140-6736(12)60987-8

  27. Chahoud J, Mrad J, Semaan A, Asmar R. Prevalence of diabetes mellitus among patients with essential arterial hypertension. J Med Liban. 2015;63(2):74-80. https://doi.org/10.12816/0012554

  28. Mills KT, Obst KM, Shen W, Molina S, Zhang HJ, He H, et al. Comparative effectiveness of implementation strategies for blood pressure control in hypertensive patients: a systematic review and meta-analysis. Ann Intern Med. 2018;168(2):110-20. https://doi.org/10.7326/M17-1805

  29. Puddey IB, Beilin LJ. Alcohol is bad for blood pressure. Clin Exp Pharmacol Physiol. 2006;33(9):847-52. https://doi.org/10.1111/j.1440- 1681.2006.04452.x

  30. Collaboration NCDRF. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389(10064):37-55. https://doi. org/10.1016/S0140-6736(16)31919-5

  31. Schiffrin EL. Global Impact of the 2017 American College of Cardiology/ American Heart Association Hypertension Guidelines: A Perspective From Canada. Circulation. 2018;137(9):883-5. https://doi.org/10.1161/ CIRCULATIONAHA.117.032849




2020     |     www.medigraphic.com